IRON CHELATION THERAPY IN MYELODYSPLASTIC SYNDROMES AND IN OTHER TRANSFUSION-DEPENDENT CHRONIC ANEMIAS. RETROSPECTIVE STUDY OF 69 PATIENTS FROM A SINGLE INSTITUTION

EHA Library, Carlo Finelli, 182646

VCAM-1 AS A NOVEL DRUG THERAPY TARGET OF BONE MARROW MESENCHYMAL STEM CELLS IN MULTIPLE MYELOMA

EHA Library, Alejandra Ortiz-Ruiz, 182647

RALA AND RALB MEDIATE CELL SURVIVAL INDEPENDENTLY OF ONCOGENIC RAS AND PROVIDE POTENTIAL THERAPEUTIC TARGETS IN MULTIPLE MYELOMA

EHA Library, Marcel Seibold, 182648

CXCR4 MUTATIONS FOUND BY USING DEEP SEQUENCING WITHOUT SORTING B CELLS, AND PROGNOSTIC IMPLICATION IN WALDENSTROM MACROBULINEMIA

EHA Library, Sung Min KIM, 182649

THE CLINICAL IMPACT OF CHROMOSOMAL TRANSLOCATION T(14;16)(Q32;Q23) IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Lenka Pavlistova, 182650

THE ROLE OF NEUROTROPHINS AND ANGIOGENIC CYTOKINES IN THE PATHOPHYSIOLOGY OF PERIPHERAL NEUROPATHY IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Karolina Łuczkowska, 182651

INFLUENCE OF XRCC5, XRCC4, NFKB2, AND BIRC5 GENES POLYMORPHISMS IN THE RISK AND PROGNOSIS OF MONOCLONAL GAMMOPATHIES

EHA Library, Ana Bela Sarmento-Ribeiro, 182652

SILENCE OF LONG NONCODING RNA MALAT1 BY RNA INTERFERENCE INHIBITS PROLIFERATION AND INDUCES APOPTOSIS IN MULTIPLE MYELOMA

EHA Library, Zuofei Chi, 182653

LONG NON-CODING RNA MEG3 FUNCTIONS AS A COMPETING ENDOGENOUS RNA TO REGULATE PTEN EXPRESSION BY SPONGING MIR-181A IN MULTIPLE MYELOMA

EHA Library, Lijuan Chen, 182654

IMPROVE RISK-STRATIFICATION OF MULTIPLE MYELOMA PATIENT WITH MICROFLUIDIC DEVICES

EHA Library, John Zhong, 182655

SERUM FREE LIGHT CHAIN RATIO IS AN INDEPENDENT RISK FACTOR FOR PROGRESSION IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE

EHA Library, Cherif Rahali, 182656

INTENSITY OF EXPRESSION OF MULTIDRUG RESISTANCE GENES AFFECT ON THE OVERALL SURVIVAL OF PATIENTS WITH MULTIPLE MYELOMA WERE TREATED WITH BORTEZOMIB AND ASSOCIATED WITH THE INITIAL MULTIDRUG RESISTANCE

EHA Library, Yulia Chernykh, 182657

ASSOCIATIONS OF IL-1, IL-4 AND TGF-Β1 POLYMORPHISMS WITH CYTOGENETIC PROFILES IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Anastasia Pavlova, 182658

CORRELATION DEPENDENCE OF CHRONIC LYMPHOPROLIFERATIVE DISORDERS, MULTIPLE MYELOMA FROM CHANGES OF IMMUNE RESPONSE GENES PROFILE

EHA Library, Elena Nazarova, 182659

FEATURES OF STROMAL ELEMENTS OF HEMATOPOIETIC BONE MARROW NICHE IN MULTIPLE MYELOMA

EHA Library, Natalya Semenova, 182660

IMPACT OF RENAL IMPAIRMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA IN A REAL WORLD SETTING.

EHA Library, Virginia Bove, 182663

THE EXPRESSION OF THE TRYPTASE POSITIVE MAST CELLS AND THE LEVELS OF IL-17, CORRELATE WITH ANGIOGENIC FACTORS IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Rodanthi Vyzoukaki, 182664

HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH DIFFERENT TREATMENT MODALITIES OF RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS IN THE US: FINDINGS FROM PREAMBLE

EHA Library, Clara Chen, 182665

ASSOCIATION OF SERUM HEAVY/LIGHT CHAIN PAIR SUPPRESSION WITH RISK FACTORS FOR PROGRESSION IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND SMOLDERING MYELOMA

EHA Library, Ignacio Isola, 182666

EXTRAMEDULLARY MYELOMA IN THE “NOVEL AGENTS ERA”: OUTCOME, HETEROGENEITIES AND PECULIARITIES OF A COHORT OF 84 PATIENTS RETROSPECTIVELY ANALYSED IN A MONOCENTRIC EXPERIENCE

EHA Library, Lorenza Torti, 182667

DINAMIC PREDICTIVE FACTORS FOR A BETTER STRATIFICATION OF PATIENTS WITH R-ISS II NEWLY DIAGNOSED MULTIPLE MYELOMA (MM)

EHA Library, Massimo Offidani, 182668

THE IMPACT OF THE UPDATED IMWG DIAGNOSTIC CRITERIA IN A REAL-LIFE SMM COHORT : A SINGLE CENTER EXPERIENCE

EHA Library, Philip Vlummens, 182669

RISK FACTORS FOR VENOUS THROMBOEMBOLISM IN 401 MULTIPLE MYELOMA PATIENTS: OBSERVATION OVER A 25-YEARS PERIOD IN A SINGLE INSTITUTION.

EHA Library, Mariana Fernandez Caballero, 182670

A PHASE III RANDOMIZED, OPEN-LABEL STUDY OF ISATUXIMAB (SAR650984) PLUS POMALIDOMIDE (POM) AND DEXAMETHASONE (DEX) VERSUS POM AND DEX IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, PAUL RICHARDSON, 182671

LONG TERM SURVIVAL OF IGM MULTIPLE MYELOMA AND WALDENSTRŐM’S MACROGLOBULINEMIA PATIENTS

EHA Library, Maria Kraj, 182672

MULTISITE PERFORMANCE EVALUATION STUDY OF THE BD ONEFLOW PLASMA CELL DISORDERS (PCD) PANEL

EHA Library, Balaji Balasa, 182673

PRACTICE GAPS AND BARRIERS TO OPTIMAL MANAGEMENT OF MULTIPLE MYELOMA PATIENTS : RESULTS FROM A MIXED-METHODS STUDY IN 8 EUROPEAN COUNTRIES.

EHA Library, Mohamad Mohty, 182674

THE EXPRESSION OF APRIL BY MULTIPLE MYELOMA CELLS AND THEIR ROLE IN THE EVOLUTION OF MULTIPLE MYELOMA

EHA Library, Peggy Kanellou, 182675

DEVELOPMENT OF SECOND PRIMARY MALIGNANCY AFTER TREATMENT WITH LENALIDOMIDE: A SINGLE CENTRE EXPERIENCE.

EHA Library, Fergal McGlynn, 182676

SOLITARY PLASMACYTOMA. A SINGLE-CENTRE RETROSPECTIVE STUDY.

EHA Library, Kyra Velazquez Kennedy, 182677

RISK STRATIFICATION ALGORITHM USING REAL-WORLD DATA FROM PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): DESCRIPTION OF CLINICAL OUTCOME BY TREATMENT REGIMEN

EHA Library, ROMAN HAJEK, 182678

LACK OF CD56 EXPRESSION IN MULTIPLE MYELOMA PATIENTS WITH RISS 2 DISEASE IS ASSOCIATED WITH WORSE PROGNOSIS AND ABOLISHED WITH AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Matevz Skerget, 182679

AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE MYELOMA IN GERMANY -REAL-WORLD DATA FROM A NATIONWIDE, MULTI-INSTITUTIONAL SURVEY IN 2015-2016

EHA Library, Maximilian Merz, 182680

MODIFIED HYPERCVAD VERSUS BORTEZOMIB-HYPERCVAD IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Emma Scott, 182681

EFFICACY AND SAFETY OF LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA: A REAL LIFE EXPERIENCE FROM TURKEY

EHA Library, Guray Saydam, 182682

OPTIMIZING THE MANAGEMENT OF NON-HEMATOLOGICAL ADVERSE EFFECTS RELATED TO LENALIDOMIDE IN RELAPSED MULTIPLE MYELOMA PATIENTS. ONE CENTER EXPERIENCE.

EHA Library, María , 182683

PROLONGED THROMBOPROPHYLAXIS IN PATIENTS TREATED WITH LENALIDOMIDE AND DEXAMETHASONE DOES NOT SEEM STRICTLY MANDATORY TO PREVENT LATE THROMBOTIC EVENTS

EHA Library, Cartia Claudio Salvatore, 182684

ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA IN THE REAL WORLD

EHA Library, Etsuko Yamazaki, 182685

RETROSPECTIVE ANALYSIS OF 121 MULTIPLE MYELOMA PATIENTS USING THE R-ISS PROGNOSTIC STAGING SYSTEM AND RESPONSE TO FIRST LINE OF TREATMENT

EHA Library, Rasha Ghonema, 182686

FEASIBILITY/PHASE II STUDY OF MYELOABLATIVE BEAM ALLOGENEIC TRANSPLANTATION FOLLOWED BY ORAL IXAZOMIB MAINTENANCE THERAPY IN PATIENTS WITH HIGH RISK MYELOMA

EHA Library, Emma Scott, 182687

EPIDEMIOLOGY OF MULTIPLE MYELOMA. THE GRANADA MYELOMA REGISTRY

EHA Library, Rafael Rios-Tamayo, 182688

REAL WORLD USE OF IXAZOMIB WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED AND RELAPSED REFRACTORY MULTIPLE MYELOMA

EHA Library, Monica Ziff, 182689

EFFICACY AND TOLERABILITY OF LENOLIDOMIDE AND POMALIDOMIDE IN RELAPSED/REFRACTORY MYELOMA PATIENTS IN A REAL WORLD STUDY

EHA Library, George Adams, 182690

APPLICATION OF CONDITIONING REGIMEN WITH BUSULFAN AND CYCLOPHOSPHAMIDE IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

EHA Library, Zhengzheng Fu, 182691

MULTIPLE MYELOMA WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT, 12 CASES AND REVIEW OF THE LITERATURE

EHA Library, Gergely Varga, 182692

DARATUMUMAB; CHALLENGES OF INTEGRATING THIS NEW THERAPY INTO STANDARD CARE.

EHA Library, Linda Little, 182693

MULTIPLE MYELOMA IN HIV+ PATIENTS LITERATURE REVIEW AND OWN CASE

EHA Library, alexis leyghton, 182694

OPTIMIZATION OF APPROACHES FOR STEM CELL MOBILIZATION FOR AUTOLOGOUS STEM CELL TRANSPLANT FOR MULTIPLE MYELOMA: PRACTICAL CONSIDERATIONS

EHA Library, Oi-Lin Lee, 182695

MINIMAL RESIDUAL DISEASE MONITORING IN MULTIPLE MYELOMA PATIENTS BY FLOW CYTOMETRY: A SINGLE CENTER EXPERIENCE

EHA Library, Svetlana Sizikova, 182696

AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY MULTIPLE MYELOMA PATIENTS

EHA Library, Michela Staderini, 182697

EVOLUTION IN THE INCIDENCE OF MONOCLONAL GAMMOPATHIES IN A SOUTHERN SPAIN TERTIARY HOSPITAL IN THE LAST THIRTEEN YEARS

EHA Library, Jose Maria Maesa, 182698

CHARACTERIZATION OF A SERIES OF PATIENTS WITH PLASMA CELL LEUKEMIA

EHA Library, Pedro Bettencourt Medeiros, 182699

OPTIMIZATION OF POMALIDOMIDE PLUS LOW DOSE DEXAMETHASONE IN REFRACTORY/RELAPSED MYELOMA MULTIPLE PATIENTS.

EHA Library, Dunia De Miguel Llorente, 182700

PROGNOSTIC SIGNIFICANCE OF PLASMABLASTIC PLASMA CELLS IN THE ERA OF NOVEL AGENTS IN MULTIPLE MYELOMA

EHA Library, Antoine Machet, 182701

INTERNATIONAL OPPORTUNITIES TO COMPARE ‘REAL WORLD’ DATA FROM MYELOMA REGISTRIES: BASELINE CHARACTERISTICS, FIRST-LINE THERAPIES AND EARLY OUTCOMES FROM AUSTRIA AND AUSTRALIA/NEW ZEALAND

EHA Library, Krystal Bergin, 182702

DETECTING EARLY RELAPSE IN MULTIPLE MYELOMA (MM) AFTER ASCT: USEFULNESS OF IMMUNEASSAYS.

EHA Library, Marcio Andrade-Campos, 182703

EARLY MORTALITY (<6 M) IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: COMPREHENSIVE INTERVENTION

EHA Library, Violeta Martinez-Robles, 182704

FIRST LINE USE OF NOVEL AGENTS BEFORE AUTOLOGOUS SCT HAS A POSITIVE IMPACT ON TIME TO SECOND PROGRESSION AND SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA UNDER 70 YEARS.

EHA Library, Susanna Gassiot, 182705

SAFETY AND EFFICACY OF NOVEL AGENTS IN VERY ELDERLY MULTIPLE MYELOMA PATIENTS (AGED 80 YEARS OR MORE): A REPORT BY THE RETE EMATOLOGICA PUGLIESE (REP)

EHA Library, Nicola Sgherza, 182706

BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VERSUS MP AS INITIAL TREATMENT FOR VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Min Kyoung KIm, 182707

EFFICACY OF AUTOLOGOUS STEM CELL TRANSPLANTATION FOR THE TREATMENT OF MULTIPLE MYELOMA IN HIV-POSITIVE PATIENTS - A CASE-SERIES

EHA Library, Ljubinka Nikolic, 182708

FEASIBILITY OF USING GLOBAL FDG UPTAKE IN BONE MARROW TO ASSESS TREATMENT RESPONSE IN MULTIPLE MYELOMA.

EHA Library, Brian Østergaard, 182709

VALUE OF MYELOMA PROGNOSTIC INDICES IN ERA OF NOVEL DRUGS IN TRANSPLANT SETTING

EHA Library, Viktor Zatezalo, 182710

WHICH ORGAN SHOULD WE BIOPSY TO DIAGNOSE AL AMYLOIDOSIS ?

EHA Library, Laura Llorente, 182711

A COMPARISON OF CYCLOPHOSPHAMIDE-GLUCOCORTICOIDS AND LENALIDOMIDE-DEXAMETHASONE AS TREATMENT FOR MULTIPLE MYELOMA IN FIRST RELAPSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Russell Sterrett, 182712

CLINICAL IMPACT OF THE PLASMA LENALIDOMIDE CONCENTRATION AND THE ANALYSIS OF ANTI-TUMOR IMMUNE RESPONSE IN NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE AND DEXAMETHASONE THERAPY

EHA Library, Takahiro Kobayashi, 182713

THE ROLE OF EXPRESSION CD56 ON BONE MARROW PLASMA CELLS AND EXTRAMEDULLARY PLASMA CELLS IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Maiia Soloveva, 182714

BENDAMUSTINE-BORTEZOMIB-DESAMETASONE (BVD) IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA

EHA Library, Claudio Cerchione, 182715

VE-CADHERIN IN MULTIPLE MYELOMA: AN INDEPENDENT PROGNOSTIC FACTOR FOR PROGRESSION-FREE SURVIVAL

EHA Library, Boris Samura, 182716

THE UTILITY OF FACS PURIFICATION OF PLASMA CELLS FOR FISH ANALYSIS IN MONOCLONAL GAMMOPATHIES

EHA Library, Marta Pereira, 182717

CLINICAL SPECTRUM AND EVOLUTION OF MONOCLONAL GAMMOPATHY ASSOCIATED NEUROPATHY VERSUS CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY PATIENTS

EHA Library, Ja Min Byun, 182718

MOLECULAR GENETIC CRITERIA PREDICTING THE EFFICIENCY OF PERIPHERAL BLOOD HEMATOPOIETIC STEM CELLS TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Tetiana , 182719

THE INFLUENCE OF MINIMAL RESIDUAL DISEASE AND TUMOR LOAD ON THE PROGRESSION FREE SURVIVAL IN MULTIPLE MYELOMA PATIENTS

EHA Library, Andrei Garifullin, 182720

QUALITY OF RESPONSE AS PREDICTOR OF SURVIVAL AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN REAL LIFE MULTIPLE MYELOMA PATIENTS IN A SINGLE INSTITUTION

EHA Library, Ana Luisa Pinto, 182721

LEPTOMENINGEAL INFILTRATION SCREENING SHOULD BE PERFORMED IN PATIENTS DIAGNOSED WITH PLASMA CELL LEUKAEMIA.

EHA Library, Maria Queralt Salas Gay, 182722

MANAGEMENT AND OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA IN REAL-WORLD SETTINGS IN BULGARIA, CROATIA AND SLOVAKIA

EHA Library, Georgi Mihaylov, 182723

SINGLE SHOT MEDIUM DOSE MELPHALAN IN RELAPSED MM PATIENTS: A RETROSPECTIVE, SINGLE CENTER EXPERIENCE

EHA Library, Cristina Clissa, 182724

LENALIDOMIDE AT THE DOSE OF TWENTY-FIVE MG EVERY OTHER DAY IN PATIENTS AFFECTED BY MULTIPLE MYELOMA AND RENAL FAILURE : A REAL-LIFE EXPERIENCE

EHA Library, Claudio Cerchione, 182725

A FEASIBILITY-STUDY ON IMPLEMENTATION OF THE INTERNATIONAL MYELOMA WORKING GROUP RECCOMENDATIONS FOR MULTIPLE MYELOMA PATIENTS IN ROUTINE CLINICAL PRACTICE: A PERIPHERAL CENTER EXPERIENCE

EHA Library, Martina Torchio, 182726

NOCARDIOSIS PROVOKED BY NOVEL AGENTS AT RELAPSED MULTIPLE MYELOMA:CASE SERİES

EHA Library, Zahit Bolaman, 182727

LENALIDOMIDE IN PATIENTS WITH DIALYSIS-DEPENDENT END STAGE RENAL FAILURE (ESRF) AND MULTIPLE MYELOMA

EHA Library, Pietro , 182728

STUDY USE OF 18-F FDG PET / CT SCANNING INTO THE FIRST FOLLOW UP OF PATIENTS WITH MULTIPLE MYELOMA AND ASSOCIATION WITH BIOCHEMICAL RESPONSE

EHA Library, Karla Vallejo Luna, 182729

MULTIPLE MYELOMA IN BORNEO SARAWAK: A DEVELOPING WORLD’S EXPERIENCE

EHA Library, Tze Shin Leong, 182730

A RETROSPECTIVE AND PROSPECTIVE AUDIT OF RADIOLOGICAL INVESTIGATIONS FOR SUSPECTED CASES OF PLASMA CELL DYSCRASIAS/MYELOMA IN THE ALTNAGELVIN AREA HOSPITAL

EHA Library, Gavin Baker, 182731

TONI DEBRE FANCONI SYNDROME DURING MYELOMA, ABOUT 8 CASES

EHA Library, Cherif Rahali, 182732

DEPP RESPONCES WITH CARLFIZOMIB-LENALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRATORY MULTIPLE MYELOMA PATIENTS: A REAL LIFE EXPERIENCE

EHA Library, Vincenzo Pavone, 182733

CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL-LIFE EXPERIENCE

EHA Library, Claudio Cerchione, 182734

IMWG ´14 DIAGNOSTIC CRITERIA TO INITIATE TREATMENT IN NEW DIAGNOSED MULTIPLE MYELOMA (NDMM): REAL-WORLD STADISTICS

EHA Library, FERNANDO ESCALANTE BARRIGON, 182735

POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE: A CHANCE FOR RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM). A REVIEW OF A CASE SERIES DIAGNOSED IN A SINGLE CENTER

EHA Library, Ángela Gil, 182736

ROUTINE SCREENING FOR KIT M541L IS NOT WARRANTED IN THE DIAGNOSTIC WORK UP OF PATIENTS WITH HYPEREOSINOPHILIA

EHA Library, Nick Cross, 182737

MUTATIONS OF THE JAK2 GENE AND CYTOGENETIC ABNORMALITIES ARE PREDICTIVE OF PROGRESSION TO HEMATOLOGICAL NEOPLASMS IN PATIENTS WITH IDIOPATHIC LEUKOCYTOSIS

EHA Library, Naoki Mori, 182738

EVALUATION OF EXPRESSION OF MIRNAS ISOLATED MICROVESICLES OF PATIENTS WITH MYELOFIBROSIS ASSOCIATED WITH DISEASE

EHA Library, Cintia Mascarenhas, 182739

COMPREHENSIVE STUDY OF BCR/ABL GENE EXPRESSION IN PROGRESSION OF “CLASSIC” MYELOPROLIFERATIVE DISORDERS

EHA Library, Laura Kesaeva, 182740

IMMUNOHISTOCHEMICAL ANALYSIS OF CALRETICULIN MUTATIONS IN PRIMARY MYELOFIBROSIS (PRMF) PATIENTS: RESULTS OF OUR INSTITUTION IN THE JAK2V617F MUTATED AND JAK2V617F WILD TYPE PRMF PATIENTS.

EHA Library, Süheyla Uyar Bozkurt, 182741

THE HIF1A/2A MRNA INDEX HAS A SIMILAR TREND AS THE CHANGES OF EXPRESSION MRNA CALR AND MDR1 GENES IN WHOLE BLOOD SAMPLES OF PATIENTS WITH JAK2 V617F POSITIVE MPN

EHA Library, Marina Stolyar, 182742

CD177 EXPRESSION IN PERIPHERAL BLOOD NEUTROPHILS IN HEALTH AND DISEASE STATES

EHA Library, Aya Arafat, 182743

DETECTION OF THE MUTATIONS IN GENES JAK2 AND MPL IN THE DIAGNOSIS OF CHRONIC MYELOPROLIFERATIVE DISORDERS

EHA Library, Abdukadir boboev, 182744

ASSOCIATION OF MYELOPROLIFERATIVE NEOPLASM AND LYMPHOPROLIFERATIVE DISORDER IN 3 PATIENTS

EHA Library, Barbara Foucher, 182745

CLINICAL AND ANALYTICAL DIFFERENCES BETWEEN CALR TYPE-1 AND CALR TYPE-2 MUTATION IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS: A SINGLE CENTER STUDY

EHA Library, Marta Sobas, 182746

ESSENTIAL TRHOMBOCYTHEMIA: STUDY OF TREATMENT LINES REQUIRED. EXPERIENCE OF A SINGLE CENTER

EHA Library, Mercedes Berenguer, 182747